60 DEGREES PHARMACEUTICALS, INC.
SXTPDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tafenoquine | Phase 2 | Healthy Volunteers | - | - |
Frequently asked questions
What is in 60 DEGREES PHARMACEUTICALS, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in 60 DEGREES PHARMACEUTICALS, INC.'s (SXTP) pipeline across Phase 2. Its lead program is Tafenoquine (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is 60 DEGREES PHARMACEUTICALS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SXTP biotech catalysts?→
Add SXTP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow 60 DEGREES PHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.